GHK-Cu: specifications, literature and price per milligram

What GHK-Cu is

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, also designated copper tripeptide-1. The free peptide was first isolated from human serum (Pickart & Thaler, Nature New Biology 1973), with later work associating it with copper transport.

The complex carries CAS 89030-95-5 and a molecular weight around 401.9 g/mol - very small by peptide standards. That is why it ships in 50mg and 100mg vials while a repair peptide ships in 5mg and 10mg, and why comparing vial prices across the two is meaningless.

What the published literature examined

Published work sits mainly in dermatological and cosmetic-science research. Collagen I, IV and VII transcript changes have been measured in cultured human dermal fibroblasts and in ex vivo skin (Jiang et al., Journal of Cosmetic Dermatology 2023). A review of the field (Pickart & Margolina, International Journal of Molecular Sciences 2018) draws largely on cell-culture and animal models rather than controlled human trials.

Cell-culture and ex vivo results are exactly that. They are not statements about anything applied to a person, and we do not make any.

Certificate and appearance

GHK-Cu is visibly distinctive: the copper complex is deep blue. Color is not an assay, but a vial of GHK-Cu that is not blue warrants a question.

• HPLC purity with chromatogram.
• Mass spectrometry identity consistent with the complex.
• Lot number matching the vial.

Price per milligram

This is one of the clearest per-milligram examples in the catalog. At 100mg for $57.99 list, the unit price is $0.58/mg - far below the repair peptides above, for the reason described at the top of this page. Anyone quoting GHK-Cu against BPC-157 on vial price alone is comparing a bucket to a thimble.

The free peptide and the copper complex are different analytes

GHK is the three-residue ligand glycyl-L-histidyl-L-lysine. GHK-Cu is the coordination complex formed when that ligand binds copper(II). The names are often shortened in catalogs, but an analytical specification should not shorten away the distinction. The expected mass, elemental composition, color and reference material depend on which form the supplier intends to provide.

That distinction also affects literature searches. A paper on the free tripeptide, a paper on copper ions and a paper on the GHK-Cu complex are not three names for the same experiment. The materials, controls and concentrations need to be read before their results are put into one narrative.

The blue appearance of the copper complex is useful as an immediate consistency check, but it is not identity testing. Color can be influenced by concentration, hydration, lighting, container and other colored material. A visual check can trigger a question; it cannot close one.

What the early cell-culture work actually established

A 1988 paper by Maquart and colleagues studied collagen synthesis in fibroblast culture after exposure to the tripeptide-copper complex. That is a primary cell-culture record: the experimental unit is the culture system, the measured endpoint is biochemical, and the comparison depends on the concentrations and controls used in that system.

Later fibroblast papers measured other extracellular-matrix signals, including glycosaminoglycan synthesis and matrix-metalloproteinase expression. Those experiments help map a set of laboratory observations. They should not be compressed into the claim that one marker predicts every other marker, or that a result in cultured cells establishes a result in intact tissue.

A useful summary therefore names the model every time: cultured fibroblasts, ex vivo skin, or an animal model. Removing the model from the sentence removes the boundary that makes the statement accurate.

How to read the 2023 fibroblast and ex vivo study

Jiang and colleagues examined combinations of GHK-Cu and hyaluronic acid. The cell phase measured collagen I, IV and VII transcript expression by qRT-PCR. A selected combination then moved into an ex vivo skin model, where collagen IV was quantified by immunofluorescence. Those are two linked experiments with different readouts, not one general-purpose clinical result.

The paper is also a combination study. A result from GHK-Cu plus a particular molecular weight and ratio of hyaluronic acid cannot automatically be assigned to GHK-Cu alone. The design answers a question about the tested combination under the tested conditions.

Source context belongs in the reading. The listed affiliations include companies working with the studied materials. An industry affiliation does not invalidate a result, but it is part of the conflict and replication picture a careful reader records.

Evidence scale: transcript, protein, tissue and person

A transcript measurement shows how much messenger RNA was detected under an assay. A protein measurement asks a later biological question. Tissue structure, material properties and a controlled human endpoint are later still. Movement at one level may support a hypothesis; it does not guarantee movement at every later level.

This hierarchy is especially important in cosmetic-science summaries, where transcript, protein and visible endpoints are easily placed in the same paragraph. A transparent page keeps the assay next to the result and avoids treating the most convenient endpoint as a proxy for all the others.

The same rule applies to review articles. A review can help locate experiments and compare proposed mechanisms, but the strength of a claim still comes from the design and replication of the underlying primary studies.

Analytical questions for a metal-peptide complex

A metal-peptide complex adds questions that do not appear on a plain sequence-only specification. The report should state whether identity refers to the free ligand, the copper-bound complex or both. It should also state whether the quoted content is total powder, peptide-equivalent mass or complex mass.

• Chromatography: report the method, trace and integrated related peaks rather than a purity number alone.
• Mass spectrometry: identify the species and charge-state interpretation used for the comparison.
• Copper content: when stoichiometry is material to the specification, keep the elemental result with the release record.
• Water and counter-ions: keep them separate from chromatographic purity and from net content.
• Lot linkage: match the tested sample to the inventory record before publishing a summary.

No single method necessarily answers all five questions. The testing plan should be built from the specification rather than from whichever instrument result is easiest to put on a page.

Why a 100mg vial can still need precise unit language

GHK-Cu's larger vial sizes can create false comfort. A difference of several milligrams looks small next to a 100mg label, but it can still change a price-per-milligram comparison and can reveal whether two vendors are labeling the same basis. The nominal mass and the measured mass should therefore appear as separate fields.

HPLC area percent is not a substitute for measured quantity. A result can report high chromatographic purity and still leave the amount in the vial unanswered. Conversely, a measured amount near the label does not establish that the principal component has the claimed identity. The three questions remain identity, composition and quantity.

A procurement note that another person can audit

Write the specification so a second person can release or reject the material without asking what the first person meant. Name the intended chemical form, expected mass, nominal quantity, allowed quantity range, purity method, identity method and any copper stoichiometry requirement. Record the decision beside the results rather than in a private chat.

When the public page is deliberately limited to purity and measured mass, retain the complete source record privately. Public minimization is a disclosure decision, not permission to discard the evidence needed to investigate the result later.

Primary records used for this overview

• Maquart et al., 1988, fibroblast-culture collagen synthesis: PubMed record.
• Jiang et al., 2023, GHK-Cu plus hyaluronic acid in fibroblasts and ex vivo skin: PubMed record.

Controls determine what a copper-complex experiment can show

A study of GHK-Cu can require more than one comparator. The free GHK ligand, a copper salt, the vehicle and the preformed complex can help separate effects associated with the ligand, the metal, the combination or the experimental medium. Without appropriate controls, several explanations may fit.

Concentration also needs a defined basis. A molar concentration of complex, a mass concentration of powder and a copper-equivalent concentration are not interchangeable. The method should state what was prepared and how complex formation or stability was handled in the test system.

These details are why a mechanism paragraph cannot substitute for the methods. The proposed pathway may be plausible while the experiment still answers only a narrow question under a particular medium, concentration and exposure period.

Complex stability belongs in the analytical plan

Coordination complexes can respond to pH, competing ligands and sample preparation. A report should make clear whether its method preserves the intact complex, measures the peptide ligand after separation, or quantifies copper independently. Those approaches can all be useful, but they report different things.

This is also relevant to reference standards. A laboratory comparing a sample with free GHK may confirm the ligand while leaving copper stoichiometry unresolved. Conversely, a copper result alone cannot establish the peptide identity. Orthogonal methods close different parts of the specification.

Public result summaries should therefore avoid compressing several assays into one 'purity' label. Internally, preserve the method name and basis for every reported number.

Reading combination studies without assigning every result to one ingredient

When GHK-Cu is studied with hyaluronic acid or another material, the tested combination is the experimental intervention. If the design does not include each ingredient alone under matched conditions, it may not estimate the contribution of each component.

Ratios and molecular-weight distributions can also be part of the intervention. A result from one ratio should not be generalized to every mixture bearing the same two ingredient names. The exact preparation belongs in the evidence table.

A clear research hub can still describe the result; it simply states that the finding belongs to the combination and notes which controls were available. That is more informative than assigning the entire observation to the most familiar ingredient.

From catalog name to auditable record

An auditable GHK-Cu record begins with the chemical form rather than the blue color or familiar three-letter name. It connects that form to the supplier specification, received material, sample submission, analytical methods and inventory decision. Each handoff keeps the same lot identity.

The public page then presents only the portion appropriate for its audience. It can explain the chemistry, cite primary experiments and show allowed result fields without publishing report credentials. The private file preserves the full evidence needed to answer a laboratory or counsel question.

If a future lot uses a different salt, counter-ion basis, complex specification or test method, it receives a new record. Similar appearance and product naming are not a reason to inherit the prior result.

The same rule applies to pricing. Compare the same defined form and labeled mass, then state whether the offer includes an access fee or temporary discount. A chemically mismatched bargain is not a lower price for the same material.